Insights into maleimide‐thiol conjugation chemistry: Conditions for efficient surface functionalization of nanoparticles for receptor targeting

[1]  Yuan Sun,et al.  RGD Peptide‐Based Target Drug Delivery of Doxorubicin Nanomedicine , 2017, Drug development research.

[2]  Wim E Hennink,et al.  Nanogels for intracellular delivery of biotherapeutics , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Jia Ouyang,et al.  EGFR and CD44 Dual-Targeted Multifunctional Hyaluronic Acid Nanogels Boost Protein Delivery to Ovarian and Breast Cancers In Vitro and In Vivo. , 2017, ACS applied materials & interfaces.

[4]  E. V. van Donselaar,et al.  A novel immuno-gold labeling protocol for nanobody-based detection of HER2 in breast cancer cells using immuno-electron microscopy. , 2017, Journal of structural biology.

[5]  A. Goepferich,et al.  Determination of the activity of maleimide-functionalized phospholipids during preparation of liposomes. , 2016, International journal of pharmaceutics.

[6]  Zhiyuan Zhong,et al.  cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[7]  S. Jonnalagadda,et al.  Physicochemical characterization of spray-dried PLGA/PEG microspheres, and preliminary assessment of biological response , 2016, Drug development and industrial pharmacy.

[8]  Fabian Kiessling,et al.  Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges. , 2016, International journal of pharmaceutics.

[9]  Sabrina Oliveira,et al.  Optical imaging of pre-invasive breast cancer with a combination of VHHs targeting CAIX and HER2 increases contrast and facilitates tumour characterization , 2016, EJNMMI Research.

[10]  Hua Wu,et al.  Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3 , 2016, Theranostics.

[11]  Z. Pang,et al.  RGD functionalized polymeric nanoparticles targeting periodontitis epithelial cells for the enhanced treatment of periodontitis in dogs. , 2015, Journal of colloid and interface science.

[12]  D. Irvine,et al.  Synthetic Nanoparticles for Vaccines and Immunotherapy. , 2015, Chemical reviews.

[13]  Alain Wagner,et al.  Developments and recent advancements in the field of endogenous amino acid selective bond forming reactions for bioconjugation. , 2015, Chemical Society reviews.

[14]  E. Wagner,et al.  Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond). , 2015, Chemical reviews.

[15]  Hans-Joachim Wittmann,et al.  New insights into the cross-linking and degradation mechanism of Diels-Alder hydrogels. , 2015, Journal of materials chemistry. B.

[16]  Louise Robinson,et al.  Long-term stabilization of maleimide-thiol conjugates. , 2015, Bioconjugate chemistry.

[17]  X. Banquy,et al.  Assessment of PEG on polymeric particles surface, a key step in drug carrier translation. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Zhiyuan Zhong,et al.  Click hydrogels, microgels and nanogels: emerging platforms for drug delivery and tissue engineering. , 2014, Biomaterials.

[19]  K. Greish,et al.  Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect , 2014, International journal of nanomedicine.

[20]  Alain Wagner,et al.  Developments in the field of bioorthogonal bond forming reactions-past and present trends. , 2014, Bioconjugate chemistry.

[21]  T. Vermonden,et al.  Nanoparticles Based on a Hydrophilic Polyester with a Sheddable PEG Coating for Protein Delivery , 2014, Pharmaceutical Research.

[22]  Rubel Chakravarty,et al.  Nanobody: The “Magic Bullet” for Molecular Imaging? , 2014, Theranostics.

[23]  Fabian Kiessling,et al.  Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines. , 2014, Nano letters.

[24]  Sabrina Oliveira,et al.  Targeting tumors with nanobodies for cancer imaging and therapy. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Aniruddha Roy,et al.  Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[26]  John M S Bartlett,et al.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  M. T. Gokmen,et al.  Kinetic comparison of 13 homogeneous thiol–X reactions , 2013 .

[28]  R. Kok,et al.  Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status. , 2013, Advanced drug delivery reviews.

[29]  J. Kopecka,et al.  Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier. , 2013, Current drug metabolism.

[30]  Vasilis Ntziachristos,et al.  Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[31]  S. Muyldermans,et al.  Nanobodies and their potential applications. , 2013, Nanomedicine.

[32]  James E Bear,et al.  PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. , 2012, Nano letters.

[33]  G. Esendagli,et al.  Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells , 2012, Drug development and industrial pharmacy.

[34]  V. Préat,et al.  PLGA-based nanoparticles: an overview of biomedical applications. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[35]  G. Storm,et al.  Targeting tumor antigens to dendritic cells using particulate carriers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[36]  M. Espina,et al.  Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA–PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery , 2012, International journal of nanomedicine.

[37]  Yuexian Liu,et al.  Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles. , 2012, Biomaterials.

[38]  Jinho Park,et al.  Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy , 2012, Theranostics.

[39]  Hirenkumar K. Makadia,et al.  Poly Lactic-co-Glycolic Acid ( PLGA ) as Biodegradable Controlled Drug Delivery Carrier , 2011 .

[40]  J. van der Gucht,et al.  Looped structure of flowerlike micelles revealed by 1H NMR relaxometry and light scattering. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[41]  James R. Baker,et al.  Tunable reagents for multi-functional bioconjugation: reversible or permanent chemical modification of proteins and peptides by control of maleimide hydrolysis† †Electronic supplementary information (ESI) available: Full experimental details and characterisation. See DOI: 10.1039/c1cc11114k Click he , 2011, Chemical communications.

[42]  J. Brassinne,et al.  Revealing the nature of thio-click reactions on the solid phase. , 2011, Chemical communications.

[43]  S. Sahoo,et al.  PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. , 2011, Advanced drug delivery reviews.

[44]  Jun Fang,et al.  The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.

[45]  W. Hennink,et al.  Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[46]  Christine Jérôme,et al.  Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[47]  C. van Nostrum,et al.  Synthesis and applications of biomedical and pharmaceutical polymers via click chemistry methodologies. , 2009, Bioconjugate chemistry.

[48]  Steven P Schwendeman,et al.  Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. , 2008, International journal of pharmaceutics.

[49]  Tejraj M Aminabhavi,et al.  Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[50]  H. de Haard,et al.  Properties, production, and applications of camelid single-domain antibody fragments , 2007, Applied Microbiology and Biotechnology.

[51]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[52]  R. Schiffelers,et al.  RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[53]  A. Vila,et al.  Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[54]  Robert Gurny,et al.  Current methods for attaching targeting ligands to liposomes and nanoparticles. , 2004, Journal of pharmaceutical sciences.

[55]  C. McCormick,et al.  Enhanced Coil Expansion and Intrapolymer Complex Formation of Linear Poly(methacrylic acid) Containing Poly(ethylene glycol) Grafts , 2004 .

[56]  R. Schiffelers,et al.  Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[57]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[58]  S. Sahoo,et al.  Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[59]  S. Davis,et al.  The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers. , 2001, Biochimica et biophysica acta.

[60]  R. A. Jain,et al.  The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. , 2000, Biomaterials.

[61]  F. Boury,et al.  Interfacial Properties of Mixed Polyethylene Glycol/Poly(d,l-lactide-co-glycolide) Films Spread at the Air/Water Interface , 2000 .

[62]  J. T. Oh,et al.  Quantitative analysis of polyvinyl alcohol on the surface of poly(D, L-lactide-co-glycolide) microparticles prepared by solvent evaporation method: effect of particle size and PVA concentration. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[63]  C Vigneron,et al.  Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[64]  R. Müller,et al.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.

[65]  F. Boury,et al.  Dynamic Properties of Poly(DL-lactide) and Polyvinyl Alcohol Monolayers at the Air/Water and Dichloromethane/Water Interfaces , 1995 .

[66]  M. Khan.  Kinetics and mechanism of the alkaline hydrolysis of maleimide. , 1984, Journal of pharmaceutical sciences.

[67]  F. Martin,et al.  Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting. , 1982, The Journal of biological chemistry.

[68]  S. Matsui,et al.  Hydrolysis of some N-alkylmaleimides , 1979 .

[69]  C. C. Lee,et al.  ADDUCTS FROM THE REACTION OF N-ETHYLMALEIMIDE WITH L-GCYSTEINE AND WITH GLUTATHIONE , 1961 .

[70]  J. D. Gregory.  The Stability of N-Ethylmaleimide and its Reaction with Sulfhydryl Groups , 1955 .

[71]  D. H. Marrian,et al.  Antimitotic action of maleimide and related substances. , 1949, British journal of pharmacology and chemotherapy.

[72]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[73]  R. Schiffelers,et al.  Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. , 2004, Nucleic acids research.

[74]  B. Frisch,et al.  Differential reactivity of maleimide and bromoacetyl functions with thiols: application to the preparation of liposomal diepitope constructs. , 2000, Bioconjugate chemistry.

[75]  V. Torchilin,et al.  Drug targeting. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[76]  R. Langer,et al.  Nanotechnology for biomaterials engineering: structural characterization of amphiphilic polymeric nanoparticles by 1H NMR spectroscopy. , 1997, Biomaterials.

[77]  Y. Ikada,et al.  Mechanism of amide formation by carbodiimide for bioconjugation in aqueous media. , 1995, Bioconjugate chemistry.

[78]  C. C. Lee,et al.  THE KINETICS OF REACTION BETWEEN L-CYSTEINE HYDROCHLORIDE AND SOME MALEIMIDES , 1964 .